Marie-Christine Imbert is a molecular biologist. She was previously manager of private equity risk and co-founder of science program at LGT Capital Partners, Founder of Sober-Life Addiction Treatment, and an Advisor to Global Changemakers and HEYA Palestine. She holds a PhD from MRC-LMB at Cambridge University.